Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating JNJ-77242113 for moderate to severe plaque psoriasis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JNJ-77242113

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Plaque Psoriasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING